Tom Moss, Founder and Chief Medical Officer
Dr. Tom Moss is a board-certified Pediatric Hematologist/Oncologist and Transplant specialist with over thirty years of healthcare industry experience . He was co-founder and Chief Medical officer of BIS Laboratories, a biotechnology company that was based upon the pioneering research in the detection and characterization of circulating tumor cells (CTCs) that Dr. Moss conducted while at Cedars Sinai Medical Center. After BIS was acquired by IMPATH, a national reference laboratory, Dr. Moss served as a senior member of the management team with a focus on liquid biopsy.
Dr. Moss has also served as a CMO of a stem cell company (Amorcyte) with responsibility for Phase I and II FDA registration trials; founder and executive of a FISH probe manufacturing company (CymogenDx); and Medical Director of a GMP cell processing company (Minaris). Dr. Moss has an extensive liquid biopsy research background with over 100 peer reviewed manuscripts and abstracts as well as personal experience analyzing over 40,000 blood, marrow, and stem cell samples.
Dr. Moss received his MD from the David Geffen School of Medicine at UCLA.